X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 04/12/2025 15:12

Stanley Black Exhibits Strong Prospects Despite Persisting Headwinds

SWK pushes toward $2B in cost savings as supply-chain actions, portfolio moves and shareholder returns reshape its long-term outlook.

Articles similaires

Sorry! Image not available at this time

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

zacks.com - 28/Jan 17:35

ECL's robust product lineup, innovation-driven growth and strong Q2 results underscore its long-term potential despite macroeconomic headwinds.

Sorry! Image not available at this time

Here's Why Stanley Black & Decker (SWK) is a Strong Momentum Stock

zacks.com - 29/Jan 14:50

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Sorry! Image not available at this time

Why Micron (MU) is a Top Stock for the Long-Term

zacks.com - 14:30

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium...

Sorry! Image not available at this time

Why Micron (MU) is a Top Stock for the Long-Term

zacks.com - 14:30

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium...

Sorry! Image not available at this time

Can PG's Productivity Drive Fuel EPS Gains Amid Inflation?

zacks.com - 20/Jan 17:36

Procter & Gamble depends on productivity from cost savings to supply-chain efficiencies to protect margins and support EPS as inflation pressures...

Sorry! Image not available at this time

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

zacks.com - 27/Jan 17:19

MMSI's WRAPSODY reimbursement tailwinds, expanding high-margin portfolio and strong cash flow set up growth into 2026 despite macro and forex...

Sorry! Image not available at this time

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

zacks.com - 27/Jan 17:19

MMSI's WRAPSODY reimbursement tailwinds, expanding high-margin portfolio and strong cash flow set up growth into 2026 despite macro and forex...

Sorry! Image not available at this time

Will CRMD'S Bearish 2026 View Impact DefenCath's Long-Term Adoption?

zacks.com - 23/Jan 15:59

CorMedix's DefenCath drives revenues with strong adoption, but 2026 outlook signals slower growth, raising concerns over long-term adoption.

Sorry! Image not available at this time

Will CRMD'S Bearish 2026 View Impact DefenCath's Long-Term Adoption?

zacks.com - 23/Jan 15:59

CorMedix's DefenCath drives revenues with strong adoption, but 2026 outlook signals slower growth, raising concerns over long-term adoption.

Sorry! Image not available at this time

Top Analyst Reports for Visa, AMD & Thermo Fisher

zacks.com - 16/Jan 21:33

Visa's volume-driven growth, cross-border expansion and AI investments support long-term prospects, but rising costs and regulatory risks keep the...